Results 181 to 190 of about 116,844 (296)

Aquaporin 2 is differentially expressed in granulosa cells of various stages of human follicles and is regulated by luteinizing hormone. [PDF]

Front Cell Dev Biol
Zheng Z, Tan J, Chen M, Zhang X, Liu S, Wen Y, Long L, Zhou C, Li Y.   +8 more
europepmc   +1 more source

Clinical Insights From a Case of Sifrim‐Hitz‐Weiss Syndrome With a CHD4 Variant: Expanding the Phenotypic Spectrum and Its Response to Growth Hormone Therapy

American Journal of Medical Genetics Part A, Volume 200, Issue 6, Page 1403-1410, June 2026.
ABSTRACT To enhance clinicians' understanding of Sifrim‐Hitz‐Weiss syndrome (SIHIWES), this study investigated the clinical phenotypes, genetic characteristics, and response to growth hormone therapy in a patient. A case of a patient with global developmental delay and distinctive facial features is presented.
Jianmei Zhang, Shuangzhong Chen, Guanping Dong, Suhong Yang, Ping Wang, Qiong Zhou, Pingping Wang   +6 more
wiley   +1 more source

ISUP grade upgrade prediction after radical prostatectomy: Role of Luteinizing Hormone to Testosterone ratio. [PDF]

BJUI Compass
Pan Z, Zhao R, Fan J, Zhang S, Li J, Liu B.   +5 more
europepmc   +1 more source

From Multiple Congenital Anomalies to Pituitary Gland Malformation: Wide Spectrum of Clinical Features in a Family With FOXA2 Variant

American Journal of Medical Genetics Part A, Volume 200, Issue 6, Page 1452-1457, June 2026.
ABSTRACT FOXA2 (hepatocyte nuclear factor‐3β, HNF‐3β) encodes a transcriptional activator involved in early embryogenesis, particularly in the patterning and differentiation of midline structures such as the neural tube, foregut, and pituitary gland. Its role in human pathogenesis was first suspected when patients with deletion of chromosome 20p11.2 ...
Christopher Connolly, Hemant A. Parmar, Lauren Hipp, Tomoyasu Higashimoto   +3 more
wiley   +1 more source

Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor-Positive Breast Cancer: A Cohort Study. [PDF]

J Clin Oncol
Valenza C, Zheng Y, Milano M, Trapani D, Giordano E, Guidi L, Berton Giachetti PPM, Boldrini L, Castellano G, Katrini J, Malagutti B, Antonarelli G, Conforti F, Pagan E, Bagnardi V, Kirkner GJ, Sangalli C, Dibble KE, Colleoni M, Regan MM, Munzone E, Curigliano G, Partridge AH.   +22 more
europepmc   +1 more source

Initiation and Maintenance of Low‐Dose Transdermal Testosterone in Non‐Binary Individuals: A Retrospective Audit

Clinical Endocrinology, Volume 104, Issue 6, Page 657-663, June 2026.
ABSTRACT Objective An increasing number of trans individuals, particularly those who are non‐binary, desire lower testosterone doses than those outlined in current guidelines for gender affirmation. These guidelines acknowledge the need for a tailored approach to treatment, especially for non‐binary people.
Eli Ward‐Smith, Ada S. Cheung, Peter Locke, Sav Zwickl, Brendan J. Nolan   +4 more
wiley   +1 more source

A Clinical Assessment of the Outcomes of Intrauterine Insemination Based on Mid-cycle Luteinizing Hormone Levels. [PDF]

Cureus
Riaz H, Bibi F, Gul E, Pathan S, Memon M, Chaudhry S, Baloch LB, Sana M, Kulsoom O.   +8 more
europepmc   +1 more source

Not All GLP‐1 Receptor Agonists Are Alike: Real‐World Evidence of Differential Endocrine and Dermatologic Safety

Diabetes/Metabolism Research and Reviews, Volume 42, Issue 4, May 2026.
ABSTRACT Aims Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are widely used for metabolic disorders, but emerging safety concerns include alopecia and reproductive or endocrine‐related adverse events (AEs). This study investigated the association between specific GLP‐1 RAs and these endocrine‐related AEs using a large‐scale pharmacovigilance ...
Nai Lee, Yun Kim
wiley   +1 more source

Evaluation of Recombinant Follicle-Stimulating Hormone (rFSH) Plus Recombinant Luteinizing Hormone (rLH) and rFSH Plus Human Menopausal Gonadotropin (HMG) Combination Therapies in Patients With Poor Ovarian Response Undergoing Ovarian Stimulation. [PDF]

Cureus
Ersoy E, Bademkiran MH, Demir M, Turk D.
europepmc   +1 more source

The Effect of the Intracervical Application of Follicle-Stimulating Hormone or Luteinizing Hormone on the Pattern of Expression of Gonadotrophin Receptors in the Cervix of Non-Pregnant Ewes [PDF]

Diaz, Falchi, Falchi, Feltovich, Fields, Fuchs, Fuchs, Fuchs, Halbert, Ji, Kershaw, Kershaw-Young, Kershaw-Young, Kornyei, Ledger, Leethongdee, Leethongdee, Leethongdee, Lin, Mizrachi, Mizrachi, Perry, Perry, Ponglowhapan, Ponglowhapan, Shemesh, Shemesh, Shemesh, Shemesh, Stepien, Stys, Uldbjerg, Xu   +32 more
core   +1 more source